Interleukin 12 and interferon-γ synthetic deficiency is associated with dendritic cell cytopenia after cardiac surgery

Shock

Volumn 24, Issue 1, 2005, Pages 26-33

  Yadavalli, Gopala K ^a,b   Chien, Jason W ^a,c   Wener, Kenneth M ^a,d   DeVecchio, Jennifer L ^a   Gupta, Sameer ^a   Salata, Robert A ^a   Lee, Jai H ^a   Caldeira, Christiano ^a   Auletta, Jeffery J ^a   Heinzel, Frederick P ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Dendritic cell; Endotoxin; Interferon ; Interleukin 12; Monocyte deactivation

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ACCESSORY CELL; ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD SAMPLING; BONE MARROW CELL; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPENIA; DENDRITIC CELL; FEMALE; HEART SURGERY; HUMAN; INFLAMMATION; INJURY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; OBSERVATION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY;

DENDRITIC CELLS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-23; INTERLEUKINS; NEUTRALIZATION TESTS; POSTOPERATIVE COMPLICATIONS; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; THORACIC SURGERY;

EID: 21744459078     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000167110.73129.a8     Document Type: Article

References (41)

1. Butler J, Rocker GM, Westaby S: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55:552-559, 1993.
2. Polk HC Jr, George CD, Wellhausen SR, Cost K, Davidson PR, Regan MP, Borzotta AP: A systematic study of host defense processes in badly injured patients. Ann Surg 204:282-299, 1986.
3. Hershman MJ, Cheadle WG, Appel SH, George CD, Davidson PF, Cost KM, Polk HC Jr: Comparison of antibody response with delayed hypersensitivity in severely injured patients. Arch Surg 124:339-341, 1989.
4. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC Jr: Depressed interferon-γ production and monocyte HLA-DR expression after severe injury. Arch Surg 123:1309-1312, 1988.
5. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW: Down-regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347, 1995.
6. Cheadle WG, Hershman MJ, Wellhausen SR, Polk HC Jr: HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 161:639-645, 1991.
7. Weighardt H, Heidecke CD, Westerholt A, Emmanuilidis K, Maier S, Veit M, Gerauer K, Matevossian E, Ulm K, Siewert JR, Holzmann B: Impaired monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis. Ann Surg 235:560-567, 2002.
8. Murray HW: Current and future clinical applications of interferon-γ in host antimicrobial defense, intensive Care Med 22(Suppl 4):S456-S461, 1996.
9. Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P, Trinchieri G: Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 25:672-676, 1995.
10. Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133-146, 2003.
11. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA: Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169:4279-4287, 2002.
12. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K: Regulation of interferon-γ production by IL-12 and IL-18. Curr Opin Immunol 10:259-264, 1998.
13. Zhang T, Kawakami K, Qureshi MH, Okamura H, Kurimoto M, Saito A: Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of γ interferon by natural killer cells. Infect Immun 65:3594-3599, 1997.
14. Pierangeli SS, Polk HC Jr, Parmely MJ, Sonnenfeld G: Murine interferon-γ enhances resistance to infection with strains of Pseudomonas aeruginosa in mice. Cytokine 5:230-234, 1993.
15. Zisman DA, Kunkel SL, Strieter RM, Gauldie J, Tsai WC, Bramson J, Wilkowski JM, Bucknell KA, Standiford TJ: Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis. Shock 8:349-356, 1997.
16. Hershman MJ, Polk HC Jr, Pietsch JD, Kuftinec D, Sonnenfeld G: Modulation of Klebsiella pneumoniae infection of mice by interferon-γ. Clin Exp Immunol 72:406-409, 1988.
17. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, Barnes PF, Rollinghoff M, Bolcskei PL, Wagner M, Akira S, Norgard MV, Belisle JT, Godowski PJ, Bloom BR, Modlin RL: Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291:1544-1547, 2001.
18. Takeuchi O, Hoshino K, Akira S: Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165:5392-5396, 2000.
19. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549, 1993.
20. Ertel W, Keel M, Neidhardt R, Steckholzer U, Kremer JP, Ungethuem U, Trentz O: Inhibition of the defense system stimulating interleukin-12 interferon-γ pathway during critical illness. Blood 89:1612-1620, 1997.
21. Weighardt H, Heidecke CD, Emmanuilidis K, Maier S, Barrels H, Siewert JR, Holzmann B: Sepsis after major visceral surgery is associated with sustained and interferon-γ-resistant defects of monocyte cytokine production. Surgery 127:309-315, 2000.
22. Naldini A, Borrelli E, Cesari S, Giomarelli P, Toscano M: In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary bypass. Cytokine 7:165-170, 1995.
23. Elsasser-Beile U, von Kleist S, Gallati H: Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J Immunol Methods 139:191-195, 1991.
24. Upham JW, Lee PT, Holt BJ, Heaton T, Prescott SL, Sharp MJ, Sly PD, Holt PG: Development of interleukin-12-producing capacity throughout childhood. Infect Immun 70:6583-6588, 2002.
25. Ito T, Amakawa R, Inaba M, Ikehara S, Inaba K, Fukuhara S: Differential regulation of human blood dendritic cell subsets by IFNs. J Immunol 166:2961-2969, 2001.
26. Trinchieri G, Pflanz S, Kastelein RA: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19:641-644, 2003.
27. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048, 1993.
28. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W: Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat Med 3:678-681, 1997.
29. Ayala A, Urbanich MA, Herdon CD, Chaudry IH: Is sepsis-induced apoptosis associated with macrophage dysfunction? J Trauma 40:568-573; discussion 573-564, 1996.
30. Schwacha MG, Chaudry IH: The cellular basis of post-burn immunosuppression: macrophages and mediators. Int J Mol Med 10:239-243, 2002.
31. Thoma-Uszynski S, Kiertscher SM, Ochoa MT, Bouis DA, Norgard MV, Miyake K, Godowski PJ, Roth MD, Modlin RL: Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol 165:3804-3810, 2000.
32. De Smedt T, Pajak B, Klaus GG, Noelle RJ, Urbain J, Leo O, Moser M: Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol 161:4476-4479, 1998.
33. Reis e Sousa C, Yap G, Schulz O, Rogers N, Schito M, Aliberti J, Hieny S, Sher A: Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 11:637-647, 1999.
34. Wysocka M, Robertson S, Riemann H, Caamano J, Hunter C, Mackiewicz A, Montaner LJ, Trinchieri G, Karp CL: IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J Immunol 166:7504-7513, 2001.
35. Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, Wagner TH, Cobb JP, Coopersmith C, Karl IE: Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 168:2493-2500, 2002.
36. Markewitz A, Faist E, Lang S, Hultner L, Weinhold C, Reichart B: An imbalance in T-helper cell subsets alters immune response after cardiac surgery. Eur J Cardiothorac Surg 10:61-67, 1996.
37. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, et al.: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387-1398, 1992.
38. Yoshihara R, Shiozawa S, Fujita T, Chihara K: γ Interferon is produced by human natural killer cells but not T cells during Staphylococcus aureus stimulation. Infect Immun 61:3117-3122, 1993.
39. Alcaraz AJ, Sancho L, Manzano L, Esquivel F, Carrillo A, Prieto A, Bernstein ED, Alvarez-Mon M: Newborn patients exhibit an unusual pattern of interleukin 10 and interferon γ serum levels in response to cardiac surgery. J Thorac Cardiovasc Surg 123:451-458, 2002.
40. Balkhy HH, Heinzel FP: Endotoxin fails to induce IFN-γ in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. J Immunol 162:3633-3638, 1999.
41. Meldrum DR, Partrick DA, Cleveland JC Jr, Shenkar R, Meldrum KK, Raiesdana A, Ayala A, Brown JW, Harken AH: On-pump coronary artery bypass surgery activates human myocardial NF-κB and increases TNF-α in the heart. J Surg Res 112:175-179, 2003.